25 XP   0   0   10

Harvard Bioscience Inc
Buy, Hold or Sell?

Let's analyse Harvard Bioscience Inc together

PenkeI guess you are interested in Harvard Bioscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harvard Bioscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harvard Bioscience Inc

I send you an email if I find something interesting about Harvard Bioscience Inc.

Quick analysis of Harvard Bioscience Inc (30 sec.)










What can you expect buying and holding a share of Harvard Bioscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.02
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$1.68
Expected worth in 1 year
$1.70
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$0.04
Return On Investment
1.1%

For what price can you sell your share?

Current Price per Share
$3.71
Expected price per share
$2.42 - $3.92
How sure are you?
50%

1. Valuation of Harvard Bioscience Inc (5 min.)




Live pricePrice per Share (EOD)

$3.71

Intrinsic Value Per Share

$1.41 - $1.80

Total Value Per Share

$3.09 - $3.48

2. Growth of Harvard Bioscience Inc (5 min.)




Is Harvard Bioscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$73m$74.5m-$247.5k-0.3%

How much money is Harvard Bioscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$853.7k-$2.3m$1.5m178.7%
Net Profit Margin-3.2%-8.5%--

How much money comes from the company's main activities?

3. Financial Health of Harvard Bioscience Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#111 / 169

Most Revenue
#111 / 169

Most Profit
#116 / 169

Most Efficient
#114 / 169

What can you expect buying and holding a share of Harvard Bioscience Inc? (5 min.)

Welcome investor! Harvard Bioscience Inc's management wants to use your money to grow the business. In return you get a share of Harvard Bioscience Inc.

What can you expect buying and holding a share of Harvard Bioscience Inc?

First you should know what it really means to hold a share of Harvard Bioscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Harvard Bioscience Inc is $3.71. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Harvard Bioscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Harvard Bioscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.68. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Harvard Bioscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-1.1%-0.02-0.5%-0.05-1.5%-0.03-0.8%-0.03-0.8%
Usd Book Value Change Per Share-0.03-0.8%0.000.1%-0.06-1.7%-0.01-0.3%-0.01-0.3%
Usd Dividend Per Share0.010.3%0.010.1%0.000.1%0.000.1%0.000.0%
Usd Total Gains Per Share-0.02-0.5%0.010.3%-0.06-1.6%-0.01-0.2%-0.01-0.3%
Usd Price Per Share5.35-4.84-3.79-4.37-4.19-
Price to Earnings Ratio-31.94--14.28--4.99--47.23--111.88-
Price-to-Total Gains Ratio-317.79--58.37-62.51-438.00-214.33-
Price to Book Ratio3.18-2.83-2.19-2.46-2.27-
Price-to-Total Gains Ratio-317.79--58.37-62.51-438.00-214.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.71
Number of shares269
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.01-0.01
Gains per Quarter (269 shares)2.81-2.28
Gains per Year (269 shares)11.25-9.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16512-11-19
21211124-23-28
31816236-34-37
42421349-45-46
530264511-56-55
636325613-68-64
742376715-79-73
848427817-90-82
954488919-102-91
10605310022-113-100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%10.030.00.025.0%55.039.00.058.5%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%11.09.00.055.0%20.019.01.050.0%57.034.03.060.6%
Dividend per Share3.00.01.075.0%5.00.07.041.7%5.00.015.025.0%5.00.035.012.5%10.00.084.010.6%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%11.09.00.055.0%20.019.01.050.0%57.034.03.060.6%

Fundamentals of Harvard Bioscience Inc

About Harvard Bioscience Inc

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 10:34:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Harvard Bioscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Harvard Bioscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -6.5% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harvard Bioscience Inc:

  • The MRQ is -6.5%. The company is making a loss. -1
  • The TTM is -3.2%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-3.2%-3.3%
TTM-3.2%YOY-8.5%+5.4%
TTM-3.2%5Y-5.2%+2.0%
5Y-5.2%10Y-6.4%+1.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.5%6.2%-12.7%
TTM-3.2%6.2%-9.4%
YOY-8.5%8.0%-16.5%
5Y-5.2%7.3%-12.5%
10Y-6.4%6.8%-13.2%
1.1.2. Return on Assets

Shows how efficient Harvard Bioscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • -1.3% Return on Assets means that Harvard Bioscience Inc generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harvard Bioscience Inc:

  • The MRQ is -1.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.3%TTM-0.6%-0.7%
TTM-0.6%YOY-1.6%+0.9%
TTM-0.6%5Y-1.0%+0.4%
5Y-1.0%10Y-1.4%+0.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.3%1.2%-2.5%
TTM-0.6%1.3%-1.9%
YOY-1.6%1.9%-3.5%
5Y-1.0%2.2%-3.2%
10Y-1.4%2.0%-3.4%
1.1.3. Return on Equity

Shows how efficient Harvard Bioscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • -2.5% Return on Equity means Harvard Bioscience Inc generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harvard Bioscience Inc:

  • The MRQ is -2.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.5%TTM-1.2%-1.3%
TTM-1.2%YOY-3.2%+2.1%
TTM-1.2%5Y-2.0%+0.9%
5Y-2.0%10Y-2.4%+0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%2.5%-5.0%
TTM-1.2%2.7%-3.9%
YOY-3.2%3.7%-6.9%
5Y-2.0%3.9%-5.9%
10Y-2.4%3.8%-6.2%

1.2. Operating Efficiency of Harvard Bioscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Harvard Bioscience Inc is operating .

  • Measures how much profit Harvard Bioscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 1.0% means the company generated $0.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harvard Bioscience Inc:

  • The MRQ is 1.0%. The company is operating less efficient.
  • The TTM is 1.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ1.0%TTM1.2%-0.2%
TTM1.2%YOY-6.5%+7.7%
TTM1.2%5Y-1.1%+2.3%
5Y-1.1%10Y-0.7%-0.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%8.1%-7.1%
TTM1.2%7.6%-6.4%
YOY-6.5%10.9%-17.4%
5Y-1.1%10.1%-11.2%
10Y-0.7%10.5%-11.2%
1.2.2. Operating Ratio

Measures how efficient Harvard Bioscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are $0.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Harvard Bioscience Inc:

  • The MRQ is 0.990. The company is less efficient in keeping operating costs low.
  • The TTM is 0.985. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.990TTM0.985+0.005
TTM0.985YOY1.065-0.080
TTM0.9855Y1.007-0.021
5Y1.00710Y0.998+0.009
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9901.153-0.163
TTM0.9851.168-0.183
YOY1.0651.105-0.040
5Y1.0071.097-0.090
10Y0.9981.056-0.058

1.3. Liquidity of Harvard Bioscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Harvard Bioscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.85 means the company has $1.85 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Harvard Bioscience Inc:

  • The MRQ is 1.848. The company is able to pay all its short-term debts. +1
  • The TTM is 2.121. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.848TTM2.121-0.274
TTM2.121YOY2.307-0.185
TTM2.1215Y2.232-0.110
5Y2.23210Y2.657-0.425
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8482.302-0.454
TTM2.1212.333-0.212
YOY2.3072.588-0.281
5Y2.2322.627-0.395
10Y2.6572.623+0.034
1.3.2. Quick Ratio

Measures if Harvard Bioscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.77 means the company can pay off $0.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harvard Bioscience Inc:

  • The MRQ is 0.768. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.865. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.768TTM0.865-0.097
TTM0.865YOY0.937-0.072
TTM0.8655Y0.978-0.113
5Y0.97810Y1.382-0.404
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7681.117-0.349
TTM0.8651.127-0.262
YOY0.9371.306-0.369
5Y0.9781.430-0.452
10Y1.3821.533-0.151

1.4. Solvency of Harvard Bioscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Harvard Bioscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harvard Bioscience Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.47 means that Harvard Bioscience Inc assets are financed with 46.8% credit (debt) and the remaining percentage (100% - 46.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harvard Bioscience Inc:

  • The MRQ is 0.468. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.475. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.468TTM0.475-0.007
TTM0.475YOY0.508-0.033
TTM0.4755Y0.499-0.024
5Y0.49910Y0.426+0.073
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4680.357+0.111
TTM0.4750.360+0.115
YOY0.5080.353+0.155
5Y0.4990.365+0.134
10Y0.4260.371+0.055
1.4.2. Debt to Equity Ratio

Measures if Harvard Bioscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 88.0% means that company has $0.88 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harvard Bioscience Inc:

  • The MRQ is 0.880. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.904. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.880TTM0.904-0.024
TTM0.904YOY1.032-0.128
TTM0.9045Y0.998-0.094
5Y0.99810Y0.790+0.207
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8800.541+0.339
TTM0.9040.561+0.343
YOY1.0320.551+0.481
5Y0.9980.651+0.347
10Y0.7900.670+0.120

2. Market Valuation of Harvard Bioscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Harvard Bioscience Inc generates.

  • Above 15 is considered overpriced but always compare Harvard Bioscience Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -31.94 means the investor is paying $-31.94 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harvard Bioscience Inc:

  • The EOD is -22.153. Based on the earnings, the company is expensive. -2
  • The MRQ is -31.945. Based on the earnings, the company is expensive. -2
  • The TTM is -14.283. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.153MRQ-31.945+9.792
MRQ-31.945TTM-14.283-17.662
TTM-14.283YOY-4.990-9.293
TTM-14.2835Y-47.228+32.945
5Y-47.22810Y-111.878+64.649
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-22.15314.475-36.628
MRQ-31.94515.934-47.879
TTM-14.28316.429-30.712
YOY-4.99021.990-26.980
5Y-47.22820.830-68.058
10Y-111.87824.796-136.674
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harvard Bioscience Inc:

  • The EOD is 12.422. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 17.914. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.693. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.422MRQ17.914-5.491
MRQ17.914TTM19.693-1.779
TTM19.693YOY14.321+5.373
TTM19.6935Y9.139+10.554
5Y9.13910Y-1.076+10.215
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD12.4229.339+3.083
MRQ17.9148.949+8.965
TTM19.6931.445+18.248
YOY14.3213.453+10.868
5Y9.1395.897+3.242
10Y-1.076-0.032-1.044
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Harvard Bioscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 3.18 means the investor is paying $3.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Harvard Bioscience Inc:

  • The EOD is 2.205. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.179. Based on the equity, the company is fair priced.
  • The TTM is 2.827. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.205MRQ3.179-0.975
MRQ3.179TTM2.827+0.352
TTM2.827YOY2.189+0.638
TTM2.8275Y2.463+0.364
5Y2.46310Y2.269+0.194
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.2052.416-0.211
MRQ3.1792.753+0.426
TTM2.8272.692+0.135
YOY2.1893.294-1.105
5Y2.4633.659-1.196
10Y2.2694.236-1.967
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Harvard Bioscience Inc.

3.1. Institutions holding Harvard Bioscience Inc

Institutions are holding 78.375% of the shares of Harvard Bioscience Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31B. Riley Asset Management, LLC6.77345.31212939278-323717-9.9209
2023-12-31Punch & Associates Inv Mgmt Inc6.72440.91282918034-5000-0.1711
2023-12-31BlackRock Inc6.71470.000429138141711376.2398
2023-09-30Harvey Partners LLC5.89361.39432557500335001.3273
2023-12-31AMH Equity Ltd4.984310.39222162893215401.0059
2023-12-31Vanguard Group Inc4.84520.00032102571381691.8489
2023-12-31Dimensional Fund Advisors, Inc.4.43750.0031925635-8331-0.4308
2023-12-31Granahan Investment Management Inc..4.24820.325818434841079126.2177
2023-12-31Royce & Associates, LP3.34330.07171450829402002.8498
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC3.13870.1861362019875006.8653
2023-12-31Acadian Asset Management LLC2.32710.02091009850-54007-5.0765
2023-12-31Heartland Advisors Inc1.99670.242286646700
2023-12-31Meros Investment Management, LP1.88912.081819750126331.5652
2023-12-31Geode Capital Management, LLC1.85420.0005804636265803.4162
2023-12-31Renaissance Technologies Corp1.66010.006720378-24300-3.2632
2023-12-31State Street Corporation1.57260.0002682423143472.1475
2023-12-31Portolan Capital Management, LLC1.5490.314467217022127349.074
2023-12-31Northern Trust Corp1.07770.00054676489400.2014
2023-12-31Greenwood Capital Associates, LLC1.01670.15344120621164692.1964
2023-12-31Acuitas Investments, LLC0.75240.91223265168473535.0462
Total 66.798922.329528987101+656757+2.3%

3.2. Funds holding Harvard Bioscience Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Harvey Partners Small-Cap Opportunity4.76151.286206646600
2024-02-29Vanguard Total Stock Mkt Idx Inv2.90290.0004125983400
2024-03-28iShares Russell 2000 ETF2.19170.00629512034590.0483
2024-02-29Heartland Value Investor1.99650.539586646700
2023-12-31Acuitas US Microcap Strategy1.57340.9728682849538358.5586
2023-12-31Royce Micro-Cap Invmt1.47871.1004641759402006.6826
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.24850.00235418418000.1479
2024-01-31Fidelity Small Cap Index0.88020.006838201267861.8085
2024-02-29DFA US Targeted Value I0.85990.012537320700
2023-12-31JNL Multi-Manager Small Cap Growth A0.83970.083736440900
2023-12-31Granahan SC Advantage0.83970.826236440900
2024-03-28iShares Russell 2000 Growth ETF0.82170.013356624-415-0.1162
2024-01-31Strategic Advisers Small-Mid Cap0.79260.016934397200
2023-12-31Kennedy Micro Cap0.75140.3681326105-5242-1.582
2023-12-31Royce Micro Cap Trust0.73130.326331740000
2023-12-31Royce Capital Micro-Cap Inv0.61681.045626768000
2023-12-31M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc0.58950.314255831132105.4447
2023-12-31Granahan Inv Mgt Small Cap Discoveries0.5734.1191248670162091187.2175
2024-03-29Dimensional US Targeted Value ETF0.56190.010324385700
2024-02-29DFA US Small Cap I0.50780.006222040200
Total 25.518711.056311074997+271724+2.5%

3.3. Insider Transactions

Insiders are holding 7.285% of the shares of Harvard Bioscience Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-17James W GreenBUY250004.38

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Harvard Bioscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0280.005-668%-0.064+131%-0.010-62%-0.012-56%
Book Value Per Share--1.6831.710-2%1.716-2%1.770-5%1.847-9%
Current Ratio--1.8482.121-13%2.307-20%2.232-17%2.657-30%
Debt To Asset Ratio--0.4680.475-1%0.508-8%0.499-6%0.426+10%
Debt To Equity Ratio--0.8800.904-3%1.032-15%0.998-12%0.790+11%
Dividend Per Share--0.0110.006+100%0.005+145%0.002+451%0.001+1002%
Eps---0.042-0.020-53%-0.055+31%-0.030-29%-0.029-31%
Free Cash Flow Per Share--0.0750.067+11%-0.003+103%0.030+147%0.020+279%
Free Cash Flow To Equity Per Share---0.020-0.002-88%-0.019-6%-0.005-74%0.028-172%
Gross Profit Margin--4.4212.185+102%1.886+134%6.453-31%11.546-62%
Intrinsic Value_10Y_max--1.796--------
Intrinsic Value_10Y_min--1.405--------
Intrinsic Value_1Y_max--0.100--------
Intrinsic Value_1Y_min--0.090--------
Intrinsic Value_3Y_max--0.361--------
Intrinsic Value_3Y_min--0.316--------
Intrinsic Value_5Y_max--0.695--------
Intrinsic Value_5Y_min--0.590--------
Market Cap161093023.000-44%232303955.000209941985.500+11%164349620.500+41%189631672.425+23%182146925.838+28%
Net Profit Margin---0.065-0.032-51%-0.085+32%-0.052-20%-0.064-1%
Operating Margin--0.0100.012-17%-0.065+745%-0.011+205%-0.007+167%
Operating Ratio--0.9900.985+0%1.065-7%1.007-2%0.998-1%
Pb Ratio2.205-44%3.1792.827+12%2.189+45%2.463+29%2.269+40%
Pe Ratio-22.153+31%-31.945-14.283-55%-4.990-84%-47.228+48%-111.878+250%
Price Per Share3.710-44%5.3504.835+11%3.785+41%4.367+23%4.195+28%
Price To Free Cash Flow Ratio12.422-44%17.91419.693-9%14.321+25%9.139+96%-1.076+106%
Price To Total Gains Ratio-220.373+31%-317.789-58.367-82%62.511-608%437.999-173%214.333-248%
Quick Ratio--0.7680.865-11%0.937-18%0.978-22%1.382-44%
Return On Assets---0.013-0.006-53%-0.016+18%-0.010-24%-0.014+3%
Return On Equity---0.025-0.012-54%-0.032+30%-0.020-18%-0.024-4%
Total Gains Per Share---0.0170.010-261%-0.060+256%-0.008-50%-0.011-33%
Usd Book Value--73074000.00074272000.000-2%74519500.000-2%76835200.000-5%80202175.000-9%
Usd Book Value Change Per Share---0.0280.005-668%-0.064+131%-0.010-62%-0.012-56%
Usd Book Value Per Share--1.6831.710-2%1.716-2%1.770-5%1.847-9%
Usd Dividend Per Share--0.0110.006+100%0.005+145%0.002+451%0.001+1002%
Usd Eps---0.042-0.020-53%-0.055+31%-0.030-29%-0.029-31%
Usd Free Cash Flow--3242000.0002929250.000+11%-109500.000+103%1310300.000+147%855100.000+279%
Usd Free Cash Flow Per Share--0.0750.067+11%-0.003+103%0.030+147%0.020+279%
Usd Free Cash Flow To Equity Per Share---0.020-0.002-88%-0.019-6%-0.005-74%0.028-172%
Usd Market Cap161093023.000-44%232303955.000209941985.500+11%164349620.500+41%189631672.425+23%182146925.838+28%
Usd Price Per Share3.710-44%5.3504.835+11%3.785+41%4.367+23%4.195+28%
Usd Profit---1818000.000-853750.000-53%-2379000.000+31%-1547650.000-15%-1819375.000+0%
Usd Revenue--28153000.00028062500.000+0%28333750.000-1%32398450.000-13%29847000.000-6%
Usd Total Gains Per Share---0.0170.010-261%-0.060+256%-0.008-50%-0.011-33%
 EOD+4 -4MRQTTM+14 -22YOY+24 -125Y+12 -2410Y+12 -24

4.2. Fundamental Score

Let's check the fundamental score of Harvard Bioscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-22.153
Price to Book Ratio (EOD)Between0-12.205
Net Profit Margin (MRQ)Greater than0-0.065
Operating Margin (MRQ)Greater than00.010
Quick Ratio (MRQ)Greater than10.768
Current Ratio (MRQ)Greater than11.848
Debt to Asset Ratio (MRQ)Less than10.468
Debt to Equity Ratio (MRQ)Less than10.880
Return on Equity (MRQ)Greater than0.15-0.025
Return on Assets (MRQ)Greater than0.05-0.013
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Harvard Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.618
Ma 20Greater thanMa 504.076
Ma 50Greater thanMa 1004.215
Ma 100Greater thanMa 2004.516
OpenGreater thanClose3.640
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets137,366
Total Liabilities64,292
Total Stockholder Equity73,074
 As reported
Total Liabilities 64,292
Total Stockholder Equity+ 73,074
Total Assets = 137,366

Assets

Total Assets137,366
Total Current Assets49,038
Long-term Assets88,328
Total Current Assets
Cash And Cash Equivalents 4,283
Net Receivables 16,099
Inventory 24,716
Other Current Assets 3,940
Total Current Assets  (as reported)49,038
Total Current Assets  (calculated)49,038
+/-0
Long-term Assets
Property Plant Equipment 8,754
Goodwill 57,065
Intangible Assets 16,036
Long-term Assets Other 6,037
Long-term Assets  (as reported)88,328
Long-term Assets  (calculated)87,892
+/- 436

Liabilities & Shareholders' Equity

Total Current Liabilities26,542
Long-term Liabilities37,750
Total Stockholder Equity73,074
Total Current Liabilities
Short-term Debt 7,275
Short Long Term Debt 5,859
Accounts payable 5,554
Other Current Liabilities 6,004
Total Current Liabilities  (as reported)26,542
Total Current Liabilities  (calculated)24,692
+/- 1,850
Long-term Liabilities
Long term Debt 30,704
Capital Lease Obligations 6,210
Long-term Liabilities Other 1,476
Long-term Liabilities  (as reported)37,750
Long-term Liabilities  (calculated)38,390
+/- 640
Total Stockholder Equity
Common Stock434
Retained Earnings -145,605
Accumulated Other Comprehensive Income -14,190
Other Stockholders Equity 232,435
Total Stockholder Equity (as reported)73,074
Total Stockholder Equity (calculated)73,074
+/-0
Other
Capital Stock434
Cash and Short Term Investments 4,283
Common Stock Shares Outstanding 42,710
Current Deferred Revenue7,709
Liabilities and Stockholders Equity 137,366
Net Debt 38,490
Net Invested Capital 109,637
Net Working Capital 22,496
Property Plant and Equipment Gross 23,139
Short Long Term Debt Total 42,773



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
0
0
23,236
58,809
58,809
73,537
74,497
82,362
82,362
83,538
84,892
107,584
115,655
116,470
119,334
128,429
136,425
133,830
134,509
139,881
135,829
107,479
106,817
92,035
91,854
92,467
90,644
93,228
91,504
90,319
96,470
98,853
94,560
93,762
86,669
81,271
79,906
82,578
106,474
107,231
105,985
102,904
120,344
124,797
127,543
129,010
126,968
126,634
131,507
129,531
130,580
133,484
135,437
146,048
148,337
135,460
135,293
137,708
136,128
135,916
134,122
138,577
133,555
120,217
120,217
114,085
112,176
107,765
107,396
108,859
110,678
109,354
170,947
165,050
165,040
168,073
171,336
166,271
162,777
164,870
156,260
150,685
149,614
156,254
151,249
153,971
153,872
162,344
158,044
155,273
147,013
145,360
145,578
142,899
139,735
137,366
137,366139,735142,899145,578145,360147,013155,273158,044162,344153,872153,971151,249156,254149,614150,685156,260164,870162,777166,271171,336168,073165,040165,050170,947109,354110,678108,859107,396107,765112,176114,085120,217120,217133,555138,577134,122135,916136,128137,708135,293135,460148,337146,048135,437133,484130,580129,531131,507126,634126,968129,010127,543124,797120,344102,904105,985107,231106,47482,57879,90681,27186,66993,76294,56098,85396,47090,31991,50493,22890,64492,46791,85492,035106,817107,479135,829139,881134,509133,830136,425128,429119,334116,470115,655107,58484,89283,53882,36282,36274,49773,53758,80958,80923,23600
   > Total Current Assets 
0
0
0
46,919
46,919
44,596
44,624
44,753
44,753
45,424
44,165
48,414
47,374
47,722
49,474
55,778
58,094
56,394
57,264
61,309
58,941
51,745
69,517
55,396
55,630
55,156
53,586
53,285
51,854
50,819
57,147
54,311
49,627
49,190
44,987
43,464
43,126
44,142
46,915
48,199
45,576
47,183
47,326
58,566
52,603
62,880
49,961
51,154
51,789
51,467
51,879
58,972
61,883
72,776
73,935
60,750
61,245
64,391
65,001
50,806
52,771
56,542
52,324
50,549
50,549
46,819
46,154
45,472
45,121
45,838
47,399
47,535
55,810
53,692
54,528
54,723
50,375
48,610
52,289
53,572
48,165
44,102
43,520
51,700
49,223
53,557
55,686
61,583
59,448
56,498
51,818
51,124
52,449
52,617
50,486
49,038
49,03850,48652,61752,44951,12451,81856,49859,44861,58355,68653,55749,22351,70043,52044,10248,16553,57252,28948,61050,37554,72354,52853,69255,81047,53547,39945,83845,12145,47246,15446,81950,54950,54952,32456,54252,77150,80665,00164,39161,24560,75073,93572,77661,88358,97251,87951,46751,78951,15449,96162,88052,60358,56647,32647,18345,57648,19946,91544,14243,12643,46444,98749,19049,62754,31157,14750,81951,85453,28553,58655,15655,63055,39669,51751,74558,94161,30957,26456,39458,09455,77849,47447,72247,37448,41444,16545,42444,75344,75344,62444,59646,91946,919000
       Cash And Cash Equivalents 
0
0
0
35,817
35,817
31,182
30,156
29,385
29,385
27,025
26,459
15,313
9,321
9,186
7,577
8,223
9,773
10,515
11,593
13,867
12,365
13,245
11,271
7,632
9,848
8,242
7,047
9,357
8,605
8,969
13,797
17,889
12,459
13,800
11,658
13,698
15,883
16,801
14,645
16,588
17,043
15,719
17,217
19,704
20,088
21,747
16,237
17,916
17,237
18,655
20,285
20,681
23,749
34,098
36,931
25,771
25,837
26,434
26,734
14,134
8,031
7,402
6,090
6,744
6,744
3,631
5,345
5,596
4,599
4,724
5,836
5,733
5,991
5,624
6,661
8,173
5,030
4,934
6,845
8,335
5,882
2,629
2,806
8,317
5,815
6,237
5,548
7,821
5,433
4,259
5,144
4,508
3,789
4,324
5,340
4,283
4,2835,3404,3243,7894,5085,1444,2595,4337,8215,5486,2375,8158,3172,8062,6295,8828,3356,8454,9345,0308,1736,6615,6245,9915,7335,8364,7244,5995,5965,3453,6316,7446,7446,0907,4028,03114,13426,73426,43425,83725,77136,93134,09823,74920,68120,28518,65517,23717,91616,23721,74720,08819,70417,21715,71917,04316,58814,64516,80115,88313,69811,65813,80012,45917,88913,7978,9698,6059,3577,0478,2429,8487,63211,27113,24512,36513,86711,59310,5159,7738,2237,5779,1869,32115,31326,45927,02529,38529,38530,15631,18235,81735,817000
       Net Receivables 
0
0
0
6,449
6,449
7,489
8,185
7,604
7,604
9,135
7,999
14,395
16,416
16,117
16,738
20,354
19,414
17,435
16,918
21,482
20,410
17,355
12,539
13,429
12,503
13,968
14,354
15,724
14,101
15,359
15,207
17,171
17,240
18,518
18,617
17,559
14,943
13,455
16,595
16,632
14,513
16,272
13,837
17,589
14,587
16,906
13,623
15,078
16,170
15,066
13,602
18,976
18,858
18,872
17,420
17,655
18,090
18,870
18,343
20,883
20,793
23,464
20,660
21,420
21,420
20,979
19,578
19,921
20,240
20,743
20,183
20,449
21,917
22,424
22,128
21,463
18,788
18,388
17,085
20,704
15,425
14,710
13,879
17,766
17,074
17,391
18,340
21,834
20,274
17,847
15,023
16,705
17,737
16,903
14,983
16,099
16,09914,98316,90317,73716,70515,02317,84720,27421,83418,34017,39117,07417,76613,87914,71015,42520,70417,08518,38818,78821,46322,12822,42421,91720,44920,18320,74320,24019,92119,57820,97921,42021,42020,66023,46420,79320,88318,34318,87018,09017,65517,42018,87218,85818,97613,60215,06616,17015,07813,62316,90614,58717,58913,83716,27214,51316,63216,59513,45514,94317,55918,61718,51817,24017,17115,20715,35914,10115,72414,35413,96812,50313,42912,53917,35520,41021,48216,91817,43519,41420,35416,73816,11716,41614,3957,9999,1357,6047,6048,1857,4896,4496,449000
       Other Current Assets 
0
0
1,228
2,170
932
590
378
2,905
244
254
170
283
141
86
21
2,522
3,204
2,947
3,438
495
491
485
35,483
23,944
22,370
21,003
20,284
17,312
17,039
13,614
14,695
4,268
3,719
643
4,513
306
303
344
334
573
556
556
2,957
5,441
5,384
5,222
5,746
3,908
3,913
3,929
3,887
1,553
1,551
1,547
1,556
1,547
1,546
1,876
1,861
30,275
1,855
2,608
2,563
3,873
42
20,979
19,578
19,921
20,240
20,743
20,183
4,213
2,959
2,831
4,248
3,109
3,222
3,883
4,465
2,472
3,715
3,582
4,146
3,355
3,658
5,220
5,820
4,341
5,030
5,056
5,535
3,472
4,062
5,301
4,345
3,940
3,9404,3455,3014,0623,4725,5355,0565,0304,3415,8205,2203,6583,3554,1463,5823,7152,4724,4653,8833,2223,1094,2482,8312,9594,21320,18320,74320,24019,92119,57820,979423,8732,5632,6081,85530,2751,8611,8761,5461,5471,5561,5471,5511,5533,8873,9293,9133,9085,7465,2225,3845,4412,9575565565733343443033064,5136433,7194,26814,69513,61417,03917,31220,28421,00322,37023,94435,4834854914953,4382,9473,2042,52221861412831702542442,9053785909322,1701,22800
   > Long-term Assets 
0
0
0
11,889
11,889
28,941
29,873
0
37,609
38,114
40,727
59,169
68,281
68,748
69,860
72,651
78,331
77,436
77,245
78,572
76,888
55,734
37,300
36,639
36,224
37,311
37,058
39,943
39,650
39,500
39,323
44,542
44,933
44,572
41,682
37,807
36,780
38,436
59,559
59,032
60,409
55,721
73,018
66,231
74,940
66,130
77,007
75,480
79,718
78,064
78,701
74,512
73,554
73,272
74,402
74,710
74,048
73,317
71,127
85,110
81,351
82,035
81,231
69,668
69,668
67,266
66,022
62,293
62,275
63,021
63,279
61,819
115,137
111,358
110,512
113,350
120,961
117,661
110,488
111,298
108,095
106,583
106,094
104,554
102,026
100,414
98,186
100,761
98,596
98,775
95,195
94,236
93,129
90,282
89,249
88,328
88,32889,24990,28293,12994,23695,19598,77598,596100,76198,186100,414102,026104,554106,094106,583108,095111,298110,488117,661120,961113,350110,512111,358115,13761,81963,27963,02162,27562,29366,02267,26669,66869,66881,23182,03581,35185,11071,12773,31774,04874,71074,40273,27273,55474,51278,70178,06479,71875,48077,00766,13074,94066,23173,01855,72160,40959,03259,55938,43636,78037,80741,68244,57244,93344,54239,32339,50039,65039,94337,05837,31136,22436,63937,30055,73476,88878,57277,24577,43678,33172,65169,86068,74868,28159,16940,72738,11437,609029,87328,94111,88911,889000
       Property Plant Equipment 
0
0
1,513
1,716
1,716
2,502
2,834
3,506
3,506
3,851
3,985
5,918
6,486
6,306
6,463
6,746
6,369
6,484
6,709
7,143
6,744
6,213
4,152
3,983
3,852
4,046
4,127
4,610
4,731
4,731
4,594
4,465
4,469
4,532
4,167
3,221
3,208
3,351
3,236
3,545
3,349
3,249
3,255
3,146
3,343
3,438
3,082
3,086
3,853
3,778
4,097
4,551
4,424
4,365
4,621
4,375
4,329
4,128
4,109
5,190
5,581
5,764
5,934
5,902
5,902
5,641
5,267
4,296
4,268
4,286
4,265
4,140
5,821
5,493
5,392
5,898
5,582
5,359
5,234
4,776
4,488
4,222
4,309
3,960
11,107
10,670
3,453
3,415
10,104
9,630
3,555
3,366
3,424
3,491
3,358
8,754
8,7543,3583,4913,4243,3663,5559,63010,1043,4153,45310,67011,1073,9604,3094,2224,4884,7765,2345,3595,5825,8985,3925,4935,8214,1404,2654,2864,2684,2965,2675,6415,9025,9025,9345,7645,5815,1904,1094,1284,3294,3754,6214,3654,4244,5514,0973,7783,8533,0863,0823,4383,3433,1463,2553,2493,3493,5453,2363,3513,2083,2214,1674,5324,4694,4654,5944,7314,7314,6104,1274,0463,8523,9834,1526,2136,7447,1436,7096,4846,3696,7466,4636,3066,4865,9183,9853,8513,5063,5062,8342,5021,7161,7161,51300
       Goodwill 
0
0
0
9,562
9,149
25,774
24,973
33,195
32,609
20,757
19,816
51,346
60,035
60,156
61,293
64,554
70,495
69,557
69,341
69,938
68,703
48,964
32,961
32,227
21,167
21,775
21,891
22,906
24,028
24,267
23,463
29,028
29,479
29,503
27,637
24,827
23,191
34,334
55,323
32,108
31,362
30,989
34,642
33,416
33,986
34,065
35,741
34,209
36,061
35,369
35,946
36,200
35,497
35,554
36,318
36,605
36,682
36,839
35,938
39,822
40,339
41,081
40,858
40,357
40,357
39,735
39,624
38,032
38,398
39,259
39,837
39,969
56,239
55,665
55,801
57,304
57,375
57,239
56,637
57,381
56,792
56,958
57,647
58,590
58,219
58,424
57,987
57,689
57,356
56,232
54,851
56,260
56,618
56,771
56,222
57,065
57,06556,22256,77156,61856,26054,85156,23257,35657,68957,98758,42458,21958,59057,64756,95856,79257,38156,63757,23957,37557,30455,80155,66556,23939,96939,83739,25938,39838,03239,62439,73540,35740,35740,85841,08140,33939,82235,93836,83936,68236,60536,31835,55435,49736,20035,94635,36936,06134,20935,74134,06533,98633,41634,64230,98931,36232,10855,32334,33423,19124,82727,63729,50329,47929,02823,46324,26724,02822,90621,89121,77521,16732,22732,96148,96468,70369,93869,34169,55770,49564,55461,29360,15660,03551,34619,81620,75732,60933,19524,97325,7749,1499,562000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37
0
0
163
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000163003700000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
9,562
9,562
25,774
24,973
33,195
33,195
33,258
34,865
51,346
60,035
60,156
61,293
64,554
70,495
69,557
69,341
69,938
68,703
48,964
32,961
32,227
10,808
11,080
10,671
11,513
10,053
9,698
10,464
10,640
10,418
9,910
8,781
8,955
9,663
34,334
55,323
22,405
21,561
20,659
21,729
23,184
22,788
22,166
23,335
23,636
24,839
23,740
23,073
22,501
21,689
20,980
20,630
20,298
19,659
18,966
17,956
22,405
24,133
23,766
23,044
22,095
22,095
20,842
20,088
18,680
18,286
18,114
17,783
17,204
50,623
48,729
47,348
45,764
44,219
41,900
39,800
38,405
36,807
35,495
34,315
33,151
31,888
30,510
28,941
27,385
25,878
24,219
22,464
21,014
19,641
18,356
17,095
16,036
16,03617,09518,35619,64121,01422,46424,21925,87827,38528,94130,51031,88833,15134,31535,49536,80738,40539,80041,90044,21945,76447,34848,72950,62317,20417,78318,11418,28618,68020,08820,84222,09522,09523,04423,76624,13322,40517,95618,96619,65920,29820,63020,98021,68922,50123,07323,74024,83923,63623,33522,16622,78823,18421,72920,65921,56122,40555,32334,3349,6638,9558,7819,91010,41810,64010,4649,69810,05311,51310,67111,08010,80832,22732,96148,96468,70369,93869,34169,55770,49564,55461,29360,15660,03551,34634,86533,25833,19533,19524,97325,7749,5629,562000
       Other Assets 
0
0
10,789
10,174
9,701
26,439
27,039
34,103
34,685
34,263
36,742
53,252
61,795
62,442
63,397
65,905
71,962
70,952
70,536
71,429
70,144
49,521
33,148
32,656
32,372
33,265
32,931
35,333
34,919
34,769
34,729
40,077
40,464
40,040
37,515
34,586
33,572
35,085
56,323
55,487
53,683
52,472
63,901
63,085
63,323
62,692
65,461
65,985
69,136
67,450
67,721
69,961
69,130
68,907
69,781
70,335
69,719
69,189
67,018
73,663
75,770
76,271
75,297
63,766
63,405
61,625
60,755
57,997
58,007
58,735
59,014
57,679
2,454
1,471
1,808
1,815
1,457
401
320
2,273
1,881
1,743
1,896
8,853
812
810
7,805
12,272
5,258
14,930
14,325
7,780
0
6,411
0
0
006,41107,78014,32514,9305,25812,2727,8058108128,8531,8961,7431,8812,2733204011,4571,8151,8081,4712,45457,67959,01458,73558,00757,99760,75561,62563,40563,76675,29776,27175,77073,66367,01869,18969,71970,33569,78168,90769,13069,96167,72167,45069,13665,98565,46162,69263,32363,08563,90152,47253,68355,48756,32335,08533,57234,58637,51540,04040,46440,07734,72934,76934,91935,33332,93133,26532,37232,65633,14849,52170,14471,42970,53670,95271,96265,90563,39762,44261,79553,25236,74234,26334,68534,10327,03926,4399,70110,17410,78900
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,126
12,002
12,487
13,116
13,086
13,006
12,765
11,056
10,946
11,018
11,046
995
1,039
954
931
1,157
1,179
1,231
1,273
182
1,102
177
179
211
208
210
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002102082111791771,1021821,2731,2311,1791,1579319541,03999511,04611,01810,94611,05612,76513,00613,08613,11612,48712,00211,1260000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
15,639
6,474
6,474
8,220
7,826
15,550
15,550
12,057
12,744
19,202
26,537
24,961
25,599
29,551
36,302
33,640
33,159
35,524
32,036
33,239
32,240
23,619
22,142
20,730
18,163
21,345
18,472
17,664
21,000
24,716
17,937
17,862
14,487
14,553
13,225
12,639
34,596
31,974
30,069
27,418
31,912
34,549
33,377
32,201
30,991
31,135
33,399
31,516
30,218
29,271
31,055
40,673
40,502
40,975
39,109
39,482
39,352
40,448
43,619
43,764
39,269
42,619
42,619
37,422
36,285
35,569
34,681
33,647
33,773
28,454
91,653
88,038
84,081
85,889
90,987
85,908
85,674
83,176
80,251
74,617
72,447
79,573
74,134
75,270
76,985
78,943
81,669
77,769
75,034
73,140
71,238
67,511
65,449
64,292
64,29265,44967,51171,23873,14075,03477,76981,66978,94376,98575,27074,13479,57372,44774,61780,25183,17685,67485,90890,98785,88984,08188,03891,65328,45433,77333,64734,68135,56936,28537,42242,61942,61939,26943,76443,61940,44839,35239,48239,10940,97540,50240,67331,05529,27130,21831,51633,39931,13530,99132,20133,37734,54931,91227,41830,06931,97434,59612,63913,22514,55314,48717,86217,93724,71621,00017,66418,47221,34518,16320,73022,14223,61932,24033,23932,03635,52433,15933,64036,30229,55125,59924,96126,53719,20212,74412,05715,55015,5507,8268,2206,4746,47415,63900
   > Total Current Liabilities 
0
0
9,909
6,368
6,368
8,075
7,682
12,156
12,156
9,214
9,919
16,599
24,032
22,631
23,176
15,596
15,710
14,284
13,341
16,064
14,276
16,517
16,552
12,996
20,028
18,492
15,945
14,684
13,332
13,778
14,463
16,341
15,087
15,021
11,964
11,215
10,079
9,188
22,168
12,258
12,147
10,181
9,807
11,296
10,913
10,344
10,215
9,559
10,729
9,913
9,531
9,901
13,116
13,296
13,495
16,085
15,479
16,365
15,628
18,099
19,762
21,233
17,270
19,409
19,409
14,850
14,442
14,601
14,056
13,239
13,947
14,041
22,284
22,194
19,261
21,506
24,141
20,861
21,697
25,312
23,475
22,663
21,248
21,053
20,718
23,268
23,506
25,316
27,226
23,354
21,360
23,249
23,217
22,942
24,205
26,542
26,54224,20522,94223,21723,24921,36023,35427,22625,31623,50623,26820,71821,05321,24822,66323,47525,31221,69720,86124,14121,50619,26122,19422,28414,04113,94713,23914,05614,60114,44214,85019,40919,40917,27021,23319,76218,09915,62816,36515,47916,08513,49513,29613,1169,9019,5319,91310,7299,55910,21510,34410,91311,2969,80710,18112,14712,25822,1689,18810,07911,21511,96415,02115,08716,34114,46313,77813,33214,68415,94518,49220,02812,99616,55216,51714,27616,06413,34114,28415,71015,59623,17622,63124,03216,5999,9199,21412,15612,1567,6828,0756,3686,3689,90900
       Short-term Debt 
0
0
0
0
7
5
5
3,894
3,894
706
1,012
699
6,695
6,551
386
398
396
26
21
20
16
27
24
21
8,518
6,500
3,000
3,000
1,500
200
2,807
2,169
2,212
2,018
2,140
1,361
963
533
29
13
6
3
3
4
4
17,107
16,305
16,300
3,938
3,409
4,204
12,950
3,000
3,000
3,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
2,450
2,450
2,389
2,374
2,372
2,722
2,779
2,765
2,765
1,413
1,621
1,799
1,999
4,504
4,702
2,607
6,900
2,807
2,807
2,807
1,721
4,030
4,281
2,470
3,235
4,871
4,828
2,720
3,811
2,970
3,220
3,470
7,275
7,2753,4703,2202,9703,8112,7204,8284,8713,2352,4704,2814,0301,7212,8072,8072,8076,9002,6074,7024,5041,9991,7991,6211,4132,7652,7652,7792,7222,3722,3742,3892,4502,4505,0005,0005,0005,0005,0005,0005,0005,0003,0003,0003,00012,9504,2043,4093,93816,30016,30517,1074433613295339631,3612,1402,0182,2122,1692,8072001,5003,0003,0006,5008,518212427162021263963983866,5516,6956991,0127063,8943,8945570000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
0
0
0
2,364
0
0
0
2,372
2,722
13,263
2,765
2,765
1,413
1,621
1,799
1,999
2,207
2,407
2,607
6,900
2,807
2,807
2,807
1,721
1,970
2,220
2,470
3,235
2,720
2,720
2,720
3,811
2,970
3,220
3,470
5,859
5,8593,4703,2202,9703,8112,7202,7202,7203,2352,4702,2201,9701,7212,8072,8072,8076,9002,6072,4072,2071,9991,7991,6211,4132,7652,76513,2632,7222,3720002,3640005,00000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
2,108
2,117
2,117
3,017
2,179
3,101
3,100
3,182
3,108
5,525
5,860
6,997
11,967
6,457
6,037
5,224
5,032
6,251
6,485
5,474
3,088
4,026
3,915
3,351
3,526
4,490
3,937
3,533
3,312
5,611
5,687
5,262
3,908
4,665
3,634
3,356
4,304
4,856
4,939
4,943
4,734
4,921
5,725
5,367
5,265
4,959
4,920
4,607
4,141
4,680
4,429
4,877
4,657
4,682
4,667
5,060
5,052
6,294
7,180
8,834
6,322
15,339
8,782
6,577
6,142
6,196
5,835
5,583
5,607
5,404
7,359
7,718
5,392
7,359
7,311
6,041
5,266
5,339
6,625
6,596
5,990
5,972
6,416
7,489
5,616
4,911
6,218
6,810
5,877
6,447
5,978
4,716
6,269
5,554
5,5546,2694,7165,9786,4475,8776,8106,2184,9115,6167,4896,4165,9725,9906,5966,6255,3395,2666,0417,3117,3595,3927,7187,3595,4045,6075,5835,8356,1966,1426,5778,78215,3396,3228,8347,1806,2945,0525,0604,6674,6824,6574,8774,4294,6804,1414,6074,9204,9595,2655,3675,7254,9214,7344,9434,9394,8564,3043,3563,6344,6653,9085,2625,6875,6113,3123,5333,9374,4903,5263,3513,9154,0263,0885,4746,4856,2515,0325,2246,0376,45711,9676,9975,8605,5253,1083,1823,1003,1012,1793,0172,1172,1172,10800
       Other Current Liabilities 
0
0
2,456
3,574
4,243
4,000
4,578
3,719
4,562
4,568
5,181
8,916
9,000
7,353
8,881
6,661
6,716
6,369
5,876
7,634
5,346
8,874
13,149
8,674
7,277
8,336
9,086
6,956
7,536
9,737
7,977
8,119
6,749
7,253
5,367
4,600
4,898
4,711
17,352
6,955
6,629
4,711
4,661
5,920
4,652
-12,627
-11,715
-12,183
1,233
1,327
601
-8,211
5,101
4,679
5,206
5,763
5,199
5,696
4,984
6,150
6,602
6,535
5,153
1,620
7,425
4,971
5,197
5,533
4,901
4,331
4,942
5,239
9,659
9,308
8,803
7,956
8,611
6,586
10,274
9,124
10,370
9,608
8,892
9,589
6,635
7,823
11,797
12,904
12,181
8,104
9,121
9,621
10,148
11,171
10,461
6,004
6,00410,46111,17110,1489,6219,1218,10412,18112,90411,7977,8236,6359,5898,8929,60810,3709,12410,2746,5868,6117,9568,8039,3089,6595,2394,9424,3314,9015,5335,1974,9717,4251,6205,1536,5356,6026,1504,9845,6965,1995,7635,2064,6795,101-8,2116011,3271,233-12,183-11,715-12,6274,6525,9204,6614,7116,6296,95517,3524,7114,8984,6005,3677,2536,7498,1197,9779,7377,5366,9569,0868,3367,2778,67413,1498,8745,3467,6345,8766,3696,7166,6618,8817,3539,0008,9165,1814,5684,5623,7194,5784,0004,2433,5742,45600
   > Long-term Liabilities 
0
0
0
106
106
145
144
0
3,394
2,843
2,825
2,604
2,505
2,330
2,423
13,955
20,592
19,356
19,818
19,460
17,760
16,722
15,688
10,623
2,114
2,238
2,218
6,661
5,140
3,886
6,537
8,375
2,850
2,841
2,523
3,338
3,146
3,451
12,428
19,716
17,922
17,237
22,105
23,253
22,464
21,857
20,776
21,576
22,670
21,603
20,687
19,370
17,939
27,377
27,007
24,890
23,630
23,117
23,724
22,349
23,857
22,531
21,999
23,210
23,210
22,572
21,843
20,968
20,625
20,408
19,826
14,413
69,369
65,844
64,820
64,383
66,846
65,047
63,977
57,864
56,776
51,954
51,199
58,520
53,416
52,002
53,479
53,627
54,443
54,415
53,674
49,891
48,021
44,569
41,244
37,750
37,75041,24444,56948,02149,89153,67454,41554,44353,62753,47952,00253,41658,52051,19951,95456,77657,86463,97765,04766,84664,38364,82065,84469,36914,41319,82620,40820,62520,96821,84322,57223,21023,21021,99922,53123,85722,34923,72423,11723,63024,89027,00727,37717,93919,37020,68721,60322,67021,57620,77621,85722,46423,25322,10517,23717,92219,71612,4283,4513,1463,3382,5232,8412,8508,3756,5373,8865,1406,6612,2182,2382,11410,62315,68816,72217,76019,46019,81819,35620,59213,9552,4232,3302,5052,6042,8252,8433,3940144145106106000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,107
16,305
16,300
16,800
16,100
15,300
12,950
12,000
21,250
20,500
19,750
18,500
17,250
18,200
16,450
16,900
15,650
15,150
16,450
14,772
13,774
12,668
11,374
10,931
10,417
9,674
8,983
61,569
59,828
59,247
58,796
54,135
52,414
51,712
46,917
46,280
40,921
40,669
46,286
41,600
0
0
0
46,244
0
0
0
0
38,203
0
0
0038,203000046,24400041,60046,28640,66940,92146,28046,91751,71252,41454,13558,79659,24759,82861,5698,9839,67410,41710,93111,37412,66813,77414,77216,45015,15015,65016,90016,45018,20017,25018,50019,75020,50021,25012,00012,95015,30016,10016,80016,30016,30517,107000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,126
12,002
12,487
13,116
13,086
13,006
12,765
11,056
10,946
11,018
11,046
995
1,039
954
931
1,157
1,179
1,231
1,273
182
1,102
177
179
211
208
210
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002102082111791771,1021821,2731,2311,1791,1579319541,03999511,04611,01810,94611,05612,76513,00613,08613,11612,48712,00211,1260000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
1,274
1,292
1,348
1,537
960
993
1,020
971
1,433
1,037
953
765
888
881
1,005
985
2,319
2,296
2,342
2,386
1,237
1,108
1,112
923
2,063
1,970
2,232
2,167
4,371
4,060
3,895
3,961
4,290
4,346
3,727
3,491
4,907
5,138
4,819
4,850
6,143
5,659
5,838
6,214
4,980
4,975
5,728
5,405
4,574
4,785
4,675
4,593
2,985
2,902
2,728
2,643
3,177
3,234
3,433
3,528
1,466
7,558
5,999
5,573
5,587
3,300
3,291
3,254
2,120
1,882
2,485
2,269
4,753
4,657
4,110
10,739
8,532
2,040
8,651
7,140
1,596
1,560
1,713
0
0
001,7131,5601,5967,1408,6512,0408,53210,7394,1104,6574,7532,2692,4851,8822,1203,2543,2913,3005,5875,5735,9997,5581,4663,5283,4333,2343,1772,6432,7282,9022,9854,5934,6754,7854,5745,4055,7284,9754,9806,2145,8385,6596,1434,8504,8195,1384,9073,4913,7274,3464,2903,9613,8954,0604,3712,1672,2321,9702,0639231,1121,1081,2372,3862,3422,2962,3199851,0058818887659531,0371,4339711,0209939601,5371,3481,2921,27400000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,023
980
369
732
684
537
277
280
289
293
160
155
139
119
1,325
2,172
2,206
2,256
3,775
6,115
6,070
6,532
6,417
6,460
6,558
6,624
3,964
1,702
1,956
2,122
2,301
2,289
2,309
2,267
1,974
0
2,276
1,906
1,899
1,809
0
0
0
1,442
0
0
590
0
667
0
0
006670590001,4420001,8091,8991,9062,27601,9742,2672,3092,2892,3012,1221,9561,7023,9646,6246,5586,4606,4176,5326,0706,1153,7752,2562,2062,1721,3251191391551602932892802775376847323699801,023000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
7,597
52,335
52,335
65,317
66,671
66,812
66,812
71,481
72,148
88,381
89,118
91,509
93,735
98,879
100,123
100,190
101,350
104,357
103,793
74,240
74,577
68,416
69,712
71,737
72,481
71,883
73,032
72,655
75,470
74,137
76,623
75,900
72,182
66,718
66,681
69,939
71,878
75,257
75,916
75,486
88,432
90,248
94,166
96,809
95,977
95,499
98,108
98,015
100,362
104,213
104,382
105,375
107,835
94,485
96,184
98,226
96,776
95,468
90,503
94,813
94,286
77,598
77,598
76,663
75,891
72,196
72,715
75,212
76,905
80,900
79,294
77,012
80,959
82,184
80,349
80,363
77,103
81,694
76,009
76,068
77,167
76,681
77,115
78,701
76,887
83,401
76,375
77,504
71,979
72,220
74,340
75,388
74,286
73,074
73,07474,28675,38874,34072,22071,97977,50476,37583,40176,88778,70177,11576,68177,16776,06876,00981,69477,10380,36380,34982,18480,95977,01279,29480,90076,90575,21272,71572,19675,89176,66377,59877,59894,28694,81390,50395,46896,77698,22696,18494,485107,835105,375104,382104,213100,36298,01598,10895,49995,97796,80994,16690,24888,43275,48675,91675,25771,87869,93966,68166,71872,18275,90076,62374,13775,47072,65573,03271,88372,48171,73769,71268,41674,57774,240103,793104,357101,350100,190100,12398,87993,73591,50989,11888,38172,14871,48166,81266,81266,67165,31752,33552,3357,59700
   Common Stock
0
0
137
294
294
311
313
313
313
314
315
347
347
347
348
348
349
349
350
351
351
351
351
351
352
352
352
352
352
353
353
355
356
357
357
358
358
358
358
360
360
361
361
361
361
362
362
362
363
364
364
370
374
375
382
390
392
394
395
397
401
415
416
416
416
417
417
418
418
418
418
419
422
427
435
436
436
436
436
438
438
438
438
444
448
451
451
452
452
453
453
454
455
457
457
434
43445745745545445345345245245145144844443843843843843643643643643542742241941841841841841741741641641641540139739539439239038237537437036436436336236236236136136136136036035835835835835735735635535335335235235235235235135135135135135034934934834834734734731531431331331331129429413700
   Retained Earnings Total Equity00-142,548-141,568-142,190-140,524-137,119-139,554-132,674-133,635-133,465-133,055-132,386-131,771-130,673-129,092-124,576-125,125-122,506-122,259-119,889-122,751-122,495-121,031-116,967-117,966-117,549-117,168-116,030-114,710-113,072-112,359-111,723-94,583-93,736-94,085-92,684-92,670-93,298-94,320-95,039-78,334-77,352-77,164-77,260-78,462-78,331-79,101-79,630-80,368-80,397000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-955
-2,143
-2,637
-2,383
-1,925
-2,538
-495
-102
-69
-283
1,145
2,217
5,341
6,289
5,783
5,765
7,467
6,624
4,360
4,033
3,178
3,457
5,246
5,579
6,174
6,347
6,987
7,839
6,660
7,801
8,210
3,201
-2,759
-3,741
-335
-436
-1,834
-3,954
-5,370
-2,677
-3,896
-2,041
-1,724
-3,561
-5,722
-4,460
-6,178
-4,734
-4,863
-6,900
-6,753
-4,366
-2,644
-2,418
-2,555
-5,669
-8,233
-12,763
-10,991
-11,534
-12,000
-11,884
-13,114
-13,280
-16,658
-15,709
-13,717
-12,515
-10,676
-9,449
-12,162
-11,587
-13,532
-13,707
-14,181
-15,717
-12,689
-14,409
-13,704
-11,974
-13,066
-14,391
-13,868
-15,003
-10,027
-10,726
-13,243
-16,179
-15,052
-14,655
-14,054
-15,280
-14,190
-14,190-15,280-14,054-14,655-15,052-16,179-13,243-10,726-10,027-15,003-13,868-14,391-13,066-11,974-13,704-14,409-12,689-15,717-14,181-13,707-13,532-11,587-12,162-9,449-10,676-12,515-13,717-15,709-16,658-13,280-13,114-11,884-12,000-11,534-10,991-12,763-8,233-5,669-2,555-2,418-2,644-4,366-6,753-6,900-4,863-4,734-6,178-4,460-5,722-3,561-1,724-2,041-3,896-2,677-5,370-3,954-1,834-436-335-3,741-2,7593,2018,2107,8016,6607,8396,9876,3476,1745,5795,2463,4573,1784,0334,3606,6247,4675,7655,7836,2895,3412,2171,145-283-69-102-495-2,538-1,925-2,383-2,637-2,143-955000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,236
190,212
191,157
191,974
192,828
193,862
196,634
198,740
199,773
200,821
202,446
203,198
204,353
205,388
206,656
207,618
209,793
210,655
211,457
212,097
213,100
214,132
215,134
215,842
216,728
217,636
218,792
220,020
221,910
225,530
226,377
226,547
227,249
228,177
229,189
229,740
230,675
231,142
232,357
234,781
225,583
225,074
225,650
226,203
227,413
228,229
229,008
230,108
231,533
0
0
00231,533230,108229,008228,229227,413226,203225,650225,074225,583234,781232,357231,142230,675229,740229,189228,177227,249226,547226,377225,530221,910220,020218,792217,636216,728215,842215,134214,132213,100212,097211,457210,655209,793207,618206,656205,388204,353203,198202,446200,821199,773198,740196,634193,862192,828191,974191,157190,212189,236000000000000000000000000000000000000000000000
   Treasury Stock00000000000-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-10,668-7,419-5,668-5,668-5,668-5,668-4,470-3,264-920-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-668-66800
   Other Stockholders Equity 
0
0
0
0
131,376
149,432
150,467
0
152,012
152,964
155,637
174,011
173,971
175,617
173,731
182,407
183,701
183,470
183,672
187,311
172,502
173,328
173,004
173,204
173,959
174,308
174,231
175,540
176,193
176,581
177,177
178,145
178,943
180,425
180,591
179,050
178,174
177,151
177,769
179,354
179,792
178,479
176,696
177,329
177,571
178,844
179,983
180,767
180,846
181,982
183,460
186,103
188,172
189,352
189,787
192,134
192,112
194,130
195,051
195,755
197,187
199,134
200,453
-11,884
200,905
202,318
203,184
204,808
205,465
206,343
207,453
208,448
208,903
211,080
215,275
216,177
216,172
216,400
217,792
218,832
218,663
220,303
220,500
221,689
224,113
225,583
225,074
234,182
226,203
227,413
228,229
229,008
230,108
81,754
232,896
232,435
232,435232,89681,754230,108229,008228,229227,413226,203234,182225,074225,583224,113221,689220,500220,303218,663218,832217,792216,400216,172216,177215,275211,080208,903208,448207,453206,343205,465204,808203,184202,318200,905-11,884200,453199,134197,187195,755195,051194,130192,112192,134189,787189,352188,172186,103183,460181,982180,846180,767179,983178,844177,571177,329176,696178,479179,792179,354177,769177,151178,174179,050180,591180,425178,943178,145177,177176,581176,193175,540174,231174,308173,959173,204173,004173,328172,502187,311183,672183,470183,701182,407173,731175,617173,971174,011155,637152,964152,0120150,467149,432131,3760000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue112,250
Cost of Revenue-51,384
Gross Profit60,86660,866
 
Operating Income (+$)
Gross Profit60,866
Operating Expense-58,581
Operating Income2,2852,285
 
Operating Expense (+$)
Research Development11,764
Selling General Administrative22,780
Selling And Marketing Expenses24,108
Operating Expense58,58158,652
 
Net Interest Income (+$)
Interest Income0
Interest Expense-3,591
Other Finance Cost-106
Net Interest Income-3,697
 
Pretax Income (+$)
Operating Income2,285
Net Interest Income-3,697
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,5567,126
EBIT - interestExpense = -1,306
-2,556
176
Interest Expense3,591
Earnings Before Interest and Taxes (EBIT)2,2851,035
Earnings Before Interest and Taxes (EBITDA)9,283
 
After tax Income (+$)
Income Before Tax-2,556
Tax Provision-918
Net Income From Continuing Ops-3,263-3,474
Net Income-3,415
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses109,965
Total Other Income/Expenses Net-4,8413,697
 

Technical Analysis of Harvard Bioscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Harvard Bioscience Inc. The general trend of Harvard Bioscience Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Harvard Bioscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harvard Bioscience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.8 < 3.84 < 3.92.

The bearish price targets are: 3.48 > 3.3 > 2.42.

Tweet this
Harvard Bioscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harvard Bioscience Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harvard Bioscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harvard Bioscience Inc. The current macd is -0.18413185.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Harvard Bioscience Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Harvard Bioscience Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Harvard Bioscience Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Harvard Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartHarvard Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harvard Bioscience Inc. The current adx is 34.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Harvard Bioscience Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Harvard Bioscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harvard Bioscience Inc. The current sar is 4.29226027.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Harvard Bioscience Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harvard Bioscience Inc. The current rsi is 39.62. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Harvard Bioscience Inc Daily Relative Strength Index (RSI) ChartHarvard Bioscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harvard Bioscience Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Harvard Bioscience Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Harvard Bioscience Inc Daily Stochastic Oscillator ChartHarvard Bioscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harvard Bioscience Inc. The current cci is -96.66150651.

Harvard Bioscience Inc Daily Commodity Channel Index (CCI) ChartHarvard Bioscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harvard Bioscience Inc. The current cmo is -23.62253077.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Harvard Bioscience Inc Daily Chande Momentum Oscillator (CMO) ChartHarvard Bioscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harvard Bioscience Inc. The current willr is -77.11864407.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Harvard Bioscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harvard Bioscience Inc Daily Williams %R ChartHarvard Bioscience Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harvard Bioscience Inc.

Harvard Bioscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harvard Bioscience Inc. The current atr is 0.26092407.

Harvard Bioscience Inc Daily Average True Range (ATR) ChartHarvard Bioscience Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harvard Bioscience Inc. The current obv is -5,410,284.

Harvard Bioscience Inc Daily On-Balance Volume (OBV) ChartHarvard Bioscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harvard Bioscience Inc. The current mfi is 38.42.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Harvard Bioscience Inc Daily Money Flow Index (MFI) ChartHarvard Bioscience Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harvard Bioscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Harvard Bioscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harvard Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.618
Ma 20Greater thanMa 504.076
Ma 50Greater thanMa 1004.215
Ma 100Greater thanMa 2004.516
OpenGreater thanClose3.640
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Harvard Bioscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Harvard Bioscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Harvard Bioscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harvard Bioscience Inc

I send you an email if I find something interesting about Harvard Bioscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Harvard Bioscience Inc.

Receive notifications about Harvard Bioscience Inc in your mailbox!